We need to increase the rate of PO tx for COVID-19 crisis

Chairman Chung Ki-seok positively evaluates that the prescription rate has risen from 4% to 20% at the beginning of the year

Park Hyang, head of the quarantine team, "Additional designation at any time other than the existing 2,000 pharmacies"

In order to respond to the increase in the number of patients with COVID-19, it was pointed out that the prescription rate of treatments such as Paxlovid should be raised more than now, while continuing to maintain an environment where prescriptions are quickly prescribed.

 

It was also suggested that the fast track of the COVID-19 high-risk oral drug prescription currently prepared by the government should be repeatedly checked, and the fast track system should not be predicted to continue to be sustainable.

 

On the 17th, Jeong Ki-seok, chairman of the National Advisory Committee on Infectious Disease Crisis Response, made this announcement at a regular briefing on COVID-19.

 

Chairman Chung Ki-seok positively assessed that the prescription rate of oral treatments, which stood at only 4% earlier this year, has now risen to 20%.

 

Chung's assessment is that the prescription rate of PO drugs must rise steadily to be effective in responding to critical patients.

 

He stressed that it is very important to secure a system that can prescribe PO drugs quickly and continue to check.

 

Chairman Chung said, "The government is preparing a lot of PO drugs, but the medicine does not solve it." He said, "The system that can be prescribed the fastest in the right time is important.

 

This is why experts strongly recommended fast-track operation to the government," he explained.

 

Chairman Chung added, "We are operating a fast track, but the government should check for other system that allows high-risk groups to receive treatment first and receive treatment first," adding, "We should not predict that this will continue to be sustainable just because we have it in place." The Ministry of Health and Welfare announced that it will do its best to secure additional medical institutions and pharmacies handling oral drugs.

 

Currently, there are only 274 places that prescribe treatments taken at or above the general hospital level and only 7 upper-level general hospitals.

 

Park Hyang, head of the central disaster management headquarters, said, "There are about 10,000 one-stop hospitals, but it is true that the number of high-level general hospitals or general hospitals that can be opened at night is small." There will be more medication in the future," she said.

 

"I heard opinions on why the drug progress is slow at the medical field, and there were problems with pharmacy issues and outpatient prescriptions," Park Hyang said.

 

"In the case of Paxlovid, it seems still difficult to combine them." "Although 2,000 pharmacies have been previously secured, we are preparing to designate additional pharmacies at any time if there is an additional on-site request," she said.

 

She added, "We will continue to listen to opinions from the medical field and supplement them."